ZIM
RMD icon

Zacks Investment Management’s ResMed RMD Stock Holding History

Zacks Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$911K Sell
4,673
-14,692
-76% -$3.05M 0.01% 435
2026
Q1 		$4.35M Buy
19,365
+1,072
+6% +$267K 0.03% 242
2025
Q4 		$4.41M Buy
18,293
+371
+2% +$94.9K 0.03% 248
2025
Q3 		$4.91M Buy
17,922
+104
+0.6% +$28.4K 0.04% 219
2025
Q2 		$4.6M Buy
17,818
+37
+0.2% +$8.83K 0.04% 223
2025
Q1 		$3.98M Buy
17,781
+438
+3% +$102K 0.04% 243
2024
Q4 		$3.97M Buy
17,343
+313
+2% +$75.4K 0.04% 246
2024
Q3 		$4.16M Sell
17,030
-688
-4% -$154K 0.04% 240
2024
Q2 		$3.39M Buy
17,718
+1,083
+7% +$220K 0.04% 221
2024
Q1 		$3.29M Buy
16,635
+2,943
+21% +$539K 0.04% 254
2023
Q4 		$2.36M Sell
13,692
-2,308
-14% -$355K 0.03% 268
2023
Q3 		$2.37M Sell
16,000
-787
-5% -$142K 0.03% 252
2023
Q2 		$3.67M Buy
+16,787
New +$3.74M 0.05% 208
2022
Q2 		– Sell
-10,396
Closed -$2.52M – 636
2022
Q1 		$2.52M Buy
10,396
+530
+5% +$128K 0.04% 256
2021
Q4 		$2.57M Buy
9,866
+66
+0.7% +$17.1K 0.04% 268
2021
Q3 		$2.58M Buy
9,800
+581
+6% +$159K 0.04% 257
2021
Q2 		$2.27M Buy
9,219
+561
+6% +$118K 0.04% 276
2021
Q1 		$1.68M Sell
8,658
-8,383
-49% -$1.68M 0.03% 308
2020
Q4 		$3.62M Buy
17,041
+10,123
+146% +$2.02M 0.07% 189
2020
Q3 		$1.19M Buy
6,918
+2,147
+45% +$396K 0.02% 295
2020
Q2 		$916K Buy
+4,771
New +$781K 0.02% 311
2014
Q1 		– Sell
-5,427
Closed -$255K – 762
2013
Q4 		$255K Buy
5,427
+644
+13% +$32.6K 0.01% 599
2013
Q3 		$253K Buy
+4,783
New +$232K 0.01% 567

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Zacks Investment Management's RMD Position: Q2 2026 in Review

Zacks Investment Management reduced its ResMed (RMD) stake by 76% in Q2 2026, selling an estimated $3.05M and leaving 4,673 shares worth $911K. The position accounts for 0.01% of the portfolio, ranked #435.

Zacks Investment Management first reported a position in RMD in Q3 2013 and has held it in 23 quarters since. The position peaked at $4.91M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Zacks Investment Management held 4,673 shares of ResMed worth $911K as of Q2 2026.
  • Zacks Investment Management sold 14,692 ResMed shares in Q2 2026, an estimated $3.05M.
  • ResMed made up 0.01% of Zacks Investment Management's portfolio in Q2 2026, its #435 holding.
  • Zacks Investment Management first reported a position in ResMed in Q3 2013 and has held it in 23 quarters since.
  • Zacks Investment Management's ResMed position peaked at $4.91M in Q3 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.